Icon

NEVANAC (nda021862)- (0.1%)

NEPAFENAC HARROW EYE
0.1%
No No
2027-Jan-31 2010-Aug-19
None None
None No
NEVANAC, is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery.
0 0 0
Total Other Developers 4
Drugs with Suitability No
0.1% ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.